Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Dec 16;25(2):359–365. doi: 10.1158/1055-9965.EPI-15-0838

Table 4.

Predicted 5-year breast cancer risk for cases and controls according to the risk models and their corresponding combined risk scores

Risk scores Combined risk score
Cases
Controls

<1.5% ≥1.5% and <2.0% ≥2.0% Up Down <1.5% ≥1.5% and <2.0% ≥2.0% Up Down NRI (95% CI)



BOADICEA 9.1% 13.1% 4.7% 1.0% 0.040 (0.007, 0.073)
 <1.5% 614 33 24 377 13 4
 ≥1.5% and <2.0% 7 3 11 2 3 2
 ≥2.0% 1 2 55 1 1 2



BRCAPRO 10.7% 0% 4.7% 0.2% 0.063 (0.030, 0.094)
 <1.5% 616 50 30 382 15 4
 ≥1.5% and <2.0% 0 0 0 1 0 0
 ≥2.0% 0 0 52 0 0 3



BCRAT 14.1% 1.4% 6.8% 0.7% 0.066 (0.019, 0.110)
 <1.5% 471 45 24 256 13 4
 ≥1.5% and <2.0% 8 7 11 2 3 2
 ≥2.0% 0 0 2 0 0 0



IBIS 10.7% 1.1% 6.2% 1.7% 0.052 (0.015, 0.088)
 <1.5% 595 44 23 363 18 4
 ≥1.5% and <2.0% 5 4 13 4 2 3
 ≥2.0% 2 1 63 1 2 8

Abbreviations: CI, confidence interval; NRI, net reclassification improvement

Note: Up is a change to a higher risk category and down is a change to a lower risk category.